Sera Prognostics, Inc. (SERA)
2.09
+0.05
(+2.45%)
USD |
NASDAQ |
Oct 02, 16:00
2.11
+0.02
(+0.96%)
After-Hours: 20:00
Sera Prognostics Net Income (Quarterly) : -9.139M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -9.139M |
| March 31, 2026 | -8.399M |
| December 31, 2025 | -7.881M |
| September 30, 2025 | -7.814M |
| June 30, 2025 | -8.046M |
| March 31, 2025 | -8.187M |
| December 31, 2024 | -8.579M |
| September 30, 2024 | -7.919M |
| June 30, 2024 | -8.303M |
| March 31, 2024 | -8.097M |
| December 31, 2023 | -7.925M |
| September 30, 2023 | -7.21M |
| June 30, 2023 | -10.54M |
| Date | Value |
|---|---|
| March 31, 2023 | -10.56M |
| December 31, 2022 | -9.746M |
| September 30, 2022 | -10.71M |
| June 30, 2022 | -11.52M |
| March 31, 2022 | -12.21M |
| December 31, 2021 | -12.48M |
| September 30, 2021 | -9.859M |
| June 30, 2021 | -6.307M |
| March 31, 2021 | -6.359M |
| December 31, 2020 | -5.375M |
| September 30, 2020 | -5.072M |
| June 30, 2020 | -4.705M |
| March 31, 2020 | -4.696M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Myriad Genetics, Inc. | -43.20M |
| BioRestorative Therapies, Inc. | -2.154M |
| CareDx, Inc. | 110.64M |
| Natera, Inc. | -66.97M |
| Exagen, Inc. | -3.196M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.03M |
| Total Expenses (Quarterly) | 9.169M |
| EPS Diluted (Quarterly) | -0.181 |
| Enterprise Value | 38.98M |
| Gross Profit Margin (Quarterly) | -606.7% |
| Profit Margin (Quarterly) | -30.46K% |
| Earnings Yield | -31.75% |
| Normalized Earnings Yield | -31.75 |